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Abstract 
Background: Transforming growth factor-beta1 (TGF-β1) has been extensively studied and reported to be 
widely expressed in tissues during dentinogenesis and the supporting periodontal tissues. Aims and Objectives: 
To determine the distribution of TGF-β1 and its receptors in periodontal cells, and to gain insight into the 
potential actions of TGF-β1 in periodontal tissues. Materials and Methods: Rat periodontal cells were collected 
from the animal alveolar bone, molar teeth and its surrounding gingivae by cell-explant technique, and 
primarily characterised and cultured. Cell lysates were detected at the cellular and mRNA levels using in situ 
hybridization, RT-PCR and Western immunoblots. Results: The mRNA for TGF-β1 was highly expressed in 
cementoblasts, moderate in osteoblasts and weak in gingival fibroblasts, while TGF-β1 and its receptors (TGF-
βR-II and TGF-βR-III) were detected in all periodontal cells. At the protein levels, TGF-β1 and TGF-βR-II 
were expressed in all periodontal cell types. Conclusion: This study suggests that TGF-β1, TGF-βR-II and TGF-
βR-III are produced locally by periodontal cells and play a role in the developing periodontium through 
regulatory autocrine manners. This would implicate the regeneration capacity in PDL. 
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Introduction 
 TGF-β1 is synthesized by a variety of 
cells and present in tissues as a latent complex (1). 
The specific cell surface receptors for TGF-βs 
(TβR-I, TβR-II and TβR-III) enable a biological 
response. TGF-β1 has a powerful role in regulating 
cell proliferation and production of extracellular 
matrix proteins (2-5). These biological effects may 
arise from the autocrine activation of TGF-β1 
signalling (6,7), and stimulate proliferation of 
foetal and adult fibroblasts (8). To test the 
hypothesis that periodontal cells produce TGF-β1 
and its receptor in an autocrine manner, this study 
examined the expression of TGF-β1 and its 
receptors in primary cultured periodontal cells at 
both the protein and mRNA levels.  
Materials and Methods 
 Following the approval of the University 
Animal Research Ethics Committee, rat PDL cells 
were used for extracting proteins and RNAs, and 
standard used for culturing on coverslips for 
undertaking in situ hybridization. All cells were 
used at passage 3 - 5. Cells (4 x 104 cells/ml) were 
suspended in culture medium (DMEM), and placed 
onto sterilized coverslips area in triplicate and 
further cultured for 48 h. After fixation with 4% 
paraformaldehyde in PBS for 30 min, the cells 
were determined for the expression of TGF-β1 
mRNA using an oligonucleotide TGF-β1 probe or 
in situ hybridization described by Gao et al 1998 
(9). 
 Cells (2 x 106) in 75 cm2 flasks were 
scraped from the surface into 500 µL of lysis 
buffer, whilst DNA chains in the lysates was 
sheared using a 27-G needle. The protein 
concentration was determined using a protein assay 
kit (Bio-Rad, USA). Lysates from periodontal cells 
were mixed with a loading buffer under reducing 
conditions, and were loaded (50 µg/lane) and 
electrophoresed at 100 V using 12% acrylamide 
SDS-PAGE mini-gels. Lysates were then 
electroblotted onto a nitrocellulose membrane. 
Membranes were washed in TBST and blocked 
with 5% non-fat milk in TBST for 60 min at room 
temperature, and washed twice in TBST for 15 
min. 
 Polyclonal goat antibodies: latent form of 
TGF-β1-LAP (1 µg/ml) (R&D Systems, USA), 
mature form of TGF-β1 (5 µg/ml) (Maine 
Biotechnology, USA) and a polyclonal rabbit 
antibody for TβR-II (Upstate Biotechnology, 
USA), were used to detect TGF-β1 and TβR-II. A 
monoclonal antibody against vimentin (1 µg/ml) 
(Sigma, USA) was used to check for equal loading 
of lysates. Primary antibodies were incubated with 
the membrane overnight at 4°C, followed by 
washing with TBST as above, a cocktail of 
secondary antibody (0.3 µg/ml) of anti-goat/-
rabbit/-mouse conjugated with horse-radish 
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peroxidase were incubated, respectively, for 60 
min at room temperature. After washing, the 
membranes were developed using 
chemiluminescence solution (Amersham Life 
Science, England) for 1 min and exposed to X-ray 
film. Controls were used by non-immune serum 
and pre-adsorption of the primary antibody by the 
recombinant proteins (R&D Systems).  
RNA was isolated from cultured cells 
according to the supplier’s directions (Advanced 
Biotech, UK). The RNA concentration was 
determined at A260 using Gene Quant II, a 
RNA/DNA calculator (Pharmacia Biotech, 
England). cDNA was made from 1 µg of total 
RNA by annealing oligo-dT (at 70°C for 10 min) 
and reverse transcription (RT) with M-MLV (at 
37°C for 1 h). The RNA was then removed by 
heating (at 99°C for 5 min) and the cDNA product 
(20 µL) of each cell type was stored at -20°C. The 
primers for TGF-β1, TβR-II and TβR-III have been 
reported and characterized previously (10,11). The 
housekeeping gene β2 -microglobulin (β2MG) was 
used as an internal control. Primers for rat β2MG 
(forward: 5’-GGGACCGAGACATGTAATC-3’; 
reverse: 5’-GAAGATGGTGT GCTCATTG-3’) 
were designed from published sequences (12) 
using the GCG program Prime (Genetics Computer 
Group, USA).  
Aliquots (2 µL) of each RT reaction were 
amplified separately for genes above. The PCR 
protocol was 25 - 30 cycles of denaturing (at 95°C 
for 1 min), annealing [52°C (β2MG), 60°C (TGF-
β1 and TβR-II), and 62°C (TβR-III), respectively, 
for 30 sec] and primer extension at 72°C for 1 min, 
which was controlled by a DNA thermal cycler. 
The polymerase used was Red Hot Taq (Integrated 
Science, USA) (0.5 U in a 20 µL reaction volume). 
The sizes of the PCR products were identified on a 
2% agarose gel containing 0.4 µg/ml ethidium 
bromide, observed under UV light and 
photographed. 
 To determine the homology of the PCR 
product, DNA from each PCR reaction product for 
β2MG, TGF-β1, TβR-II or TβR-III was purified 
using a WizardTM PCR Preps DNA Purification 
System. The DNA products were quantified as 
above, and used as a template for PCR 
amplification using forward primers for β2MG, 
TGF-β1, TβR-II and TβR-III. The standard 
protocol for Dye Terminator Cycle Sequencing 
was followed (Perkin Elmer, USA). Analysis of the 
sequences confirmed that the PCR products were 
β2MG, TGF-β1, TβR-II and TβR-III, respectively.  
Results 
Using in situ hybridization, the poly-dT 
positive control probe gave a strong signal in the 
cytoplasm of all types of primary periodontal cells 
(Fig. 1A), while the negative control showed no 
signal. The mRNA for TGF-β1 was clearly 
localized in the cytoplasm of cementoblast-like, 
osteoblast-like, and PDL fibroblast-like cells in 
vitro (Fig.1B - D). 
  Western blotting using a polyclonal 
antibody against LAP (TGF-β1) showed two major 
bands at 40 and 13 KDa under reducing conditions. 
Proteins obtained from primary periodontal cells 
expressed a positive band at 40 KDa (Fig. 2A). The 
intensity of the 13 KDa band was the strongest for 
cementoblast-like cells compared with other cell 
types, and osteoblast-like cells also showed a weak 
40 KDa band (Fig. 2A). By comparison, the 
expression of LAP-TGF-β1 in the established cell 
lines of neuroblastoma (Fig. 2B) also showed the 
same pattern and size as the primary culture.  
Standard LAP (TGF-β1) protein was detected as an 
approximately 40 KDa band. When the antibody 
was pre-adsorbed by the TGF-β1-LAP protein for 
overnight, the intensity of the band was greatly 
reduced. As expected, no band was detected when 
the antibody was pre-adsorbed for a further 3 days 
(Fig. 2A). The intensity of the 73 KDa band 
corresponding to TβR-II was strongly expressed in 
each of the four cell types of periodontal cells (Fig. 
3A).  Staining with Ponceau S, and the detection of 
vimentin, both showed equal loading of protein per 
lane (Fig. 3B). Negative controls showed no 
specific bands.  
RNA was extracted from each type of 
periodontal cells as above, and adjusted to an equal 
concentration (Fig. 4A). Primers for the rat β2-
microglobulin were used to ensure that each lane 
was loaded with equal amounts of mRNA. All 
lanes showed equal intensity of the β2-
microglobulin PCR product at 130 bp (Fig. 4B). 
The mRNA for TGF-β1 and its receptors in total 
RNA extracts from cultured cells was examined by 
RT-PCR. PCR products for TGF-β1 and its 
receptor types II and III were detected at 430, 299 
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and 340 base-pairs (bp), respectively, in all primary 
periodontal cells described a above (Fig. 4C - E). 
Discussion 
PDL cells are reported to primarily 
synthesize TGF-β1 and secrete the protein locally 
in variety of tissues (8,13-15). Since TGF-β1 has a 
short half-life in the circulation, its autocrine 
production by periodontal cells may take place on a 
demand basis, when this protein is required to 
maintain periodontal homeostasis (16). The 
periodontal cementoblasts, fibroblasts and 
osteoblasts play a key role in maintaining 
homeostasis of the periodontium under 
physiological conditions, and in propagating new 
cells and producing extracellular matrix needed for 
tissue repair and regeneration during pathological 
conditions (17,18).  Previous reports indicated that 
TGF-β1 induced fibroblasts to synthesise 
proteoglycans, such as biglycan and decorin (19). 
When interacting with cells, TGF-β1 binds to a 
specific cell membrane receptor with high affinity 
(20). There is essentially no cross-reactivity 
between TGF-β1 and receptors for other growth 
factors. TGF-β receptors located on the cell surface 
or within cells may modulate the interaction of 
TGF-β1 with the target cells via the availability of 
binding sites (20,21). 
 This study has provided evidence to 
demonstrate that cultured periodontal cells express 
mRNA for TGF-β receptor types II and III, as well 
as TβR-II proteins. This suggests that these cells 
are able to synthesize those proteins and secrete 
into the local tissues. The presence of TGF-β1 and 
its receptors in periodontal tissues and cells both in 
vivo and in vitro strongly supports the view that 
TGF-β1 acts in an autocrine manner. The 
intercellular region of the TβR-II receptor has a 
serine/threonine (S/T) kinase domain and S/T 
kinase activity which is a common characteristic of 
TGF-β receptors in this superfamily of proteins for 
their signal transduction (22). Additionally, the 
Smad proteins have also been demonstrated to be 
important for signal transduction for TGF-β1 from 
receptor into nucleus (21,23).  Betaglycan (TβR-
III) could be involved in capturing and retaining 
TGF-β1 within the cellular environment for 
presentation to the signalling receptors (21,24). 
Thus, both receptors may be involved in regulating 
the actions of TGF-β1 in the periodontium. 
In this study, the 13 KDa band detected 
using western blotting may be a proteolytic 
breakdown product of the latency-associated 
protein, although proteinase inhibitors were 
properly used. To eliminate the possibility that the 
13 kDa may be a non-specific band, we have 
undertaken additional experiments. When cellular 
proteins were diluted 2.5, 5, 10 and 20 times, the 
intensity of the varied band showed from strong to 
weak. Omission of the primary antibody resulted in 
no band being present, whilst cellular proteins 
blocked the reaction of the primary antibody. The 
40 KDa band, a monomer form of LAP (1), 
demonstrates the presence of LAP (or TGF-β1) in 
periodontal cells. This suggests that periodontal 
cells contain components of the LAP-TGF-β1 
complex. This interesting result demonstrates that 
the expression of LAP (or TGF-β1) within 
periodontal cells is similar, but the degradation of 
this protein occurs more readily in cementoblasts, 
moderately in periodontal ligament and gingival 
fibroblasts, and less so in osteoblasts. RT-PCR 
analysis of total cellular RNA demonstrated the 
detectable presence of mRNA for TGF-β1 and its 
receptor types II and III in rat periodontal cells 
(11). The ability to screen for a broad range of 
cytokines and the stability of periodontal cells in 
culture makes an excellent model for studying 
normal and diseased periodontal tissues.  
 Overall, this study demonstrates the 
presence of TGF-β1and its receptor type II and III 
in primarily cultured periodontal cells. The 
expression of these molecules at the protein and the 
mRNA levels suggests the likelihood that an 
autocrine production of TGF-β1 be associated with 
expression of its receptors in vitro. It is implicated 
that the regeneration capacity is naturally present in 
PDL. 
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